FDA Approves First Gene Therapy for Fatal Childhood Brain Disease
US regulators approved Fayuvi, a one-time gene therapy from Ultragenyx, as the first treatment for Sanfilippo syndrome type A, a rare inherited disease that progressively destroys the brains of young children.
